Brian P. Dunleavy

Brian P. Dunleavy has been covering health and medical research for more than 25 years, for United Press International and EverydayHealth.com, among other outlets. He is also the former editor of Infectious Disease Special Edition. In addition, he has written on other subjects for Biography.com, History.com, the Village Voice and amNewYork, among others. He holds a master’s degree from the University of Missouri School of Journalism.

Articles by Brian P. Dunleavy

With more than 90 locally transmitted cases of Zika virus infection confirmed in Florida, and states from the southeast to the Midwest fearing similar outbreaks, the Centers for Disease Control and Prevention (CDC) has made bolstering its network of approved testing laboratories for the virus a priority.

The Centers for Disease Control and Prevention may revisit its travel guidance on south Florida as soon as early next week, if there are no new cases involving local transmission of the Zika virus in the region; however, local businesses continue to be impacted.

Using the mainstream media as the medium for their message, some of the nation’s leading physicians urged Congress to pass a “clean, bipartisan funding measure” to fight the spread of Zika, both in the United States and abroad, and to “protect pregnant women” from the complications associated with the virus.

On September 5, officials in the Philippines confirmed the first case of Zika in the nation, an indication that the virus is spreading throughout much of Asia.

American Olympic athletes returned from the 2016 Summer Olympics in Rio de Janeiro with a record medal haul—121 in all, including 46 golds. More importantly, though, none of them came home with the Zika virus, at least according to the most recent reports from the US Olympic Committee.

Researchers at the NIH’s National Center for Advancing Translational Sciences (NCATS), working with colleagues at Johns Hopkins and Florida State University have identified compounds that “potentially can be used to inhibit Zika virus replication and reduce its ability to kill brain cells.”